Concepedia

Yair Herishanu

YH

52

Publications

2.4K

Citations

26

H-Index

2001

Active since

Affiliations

Tel Aviv Sourasky Medical Center(Current)

Tel Aviv University

Kaplan Medical Center

Rabin Medical Center

Shaare Zedek Medical Center

Yair Herishanu is an author at Tel Aviv Sourasky Medical Center specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2001–2025

52

Publications

52

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial

Jeff P. Sharman, Miklós Egyed, Wojciech Jurczak et al. · The Lancet · 2020 · 583 citations · Full text

, , +8

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin et al. · Leukemia · 2020 · 271 citations · Full text

Ibrutinib‐associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non‐Hodgkin lymphoma: An observational study

Rosa Ruchlemer, Ronen Ben‐Ami, Maskit Bar‐Meir et al. · Mycoses · 2019 · 79 citations · Full text

Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma

Irit Avivi, Roi Balaban, Tamir Shragai et al. · British Journal of Haematology · 2021 · 73 citations · Full text

The Cytokine Midkine and Its Receptor RPTPζ Regulate B Cell Survival in a Pathway Induced by CD74

Sivan Cohen, Or-yam Shoshana, Einat Zelman-Toister et al. · The Journal of Immunology · 2011 · 70 citations · Full text

Rows per page

1–5 of 52